Mayo Clinic Q&A: Cardiac Risks of Off-Label Drugs to Treat COVID-19

Everyone
  • 1 video | 15m 50s
Likes 36 Likes 36
A study published recently in Mayo Clinic Proceedings details information about potential cardiac side effects when using off-label drugs to treat COVID-19. Off-label means the drug has been approved by the Food and Drug Administration to treat a different condition. Some of the off-label drugs being used to treat COVID-19 have a risk of sudden cardiac arrest and death. (Published 04/08/2020)

IN THIS COURSE

  • 15m 51s
    On the Mayo Clinic Q&A podcast, Dr. Michael Ackerman, a Mayo Clinic genetic cardiologist and director of the  Windland Smith Rice Sudden Death Genomics Laboratory, explains how heart monitoring is important to identify at-risk patients. (Published 04/08/2020) FREE ACCESS

PEOPLE WHO VIEWED THIS ALSO VIEWED THESE